COMPANY OVERVIEW

None

---

LOCATION

---

THERAPEUTIC AREAS

---

WEBSITE

https://genelux.com/

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

PRESS RELEASES

May 7, 2020

Genelux Corporation Announces Productive Type C Meeting with FDA

Jun 4, 2018

Results from Genelux Corporation's Phase 1b Trial of GL-ONC1 in Recurrent Ovarian Cancer to be presented at the ASCO Annual Meeting 2018

Feb 23, 2017

Imanis Life Sciences Launches Line of Oncolytic Vaccinia Viruses Encoding Reporter Genes From Genelux Corporation

Nov 1, 2012

Genelux Corporation Announces Early Results of a Phase I/II Clinical Trial of Virotherapeutic GL-ONC1 in Advanced Peritoneal Cavity Cancers

Jun 28, 2012

Genelux Corporation Announces Ground-Breaking Clinical Study Evaluating Oncolytic Vaccinia Virus in Canine Cancer Patients

For More Press Releases

---